Verix Achieves ‘More’ in 2013

,
It’s been a prolific year for Verix! If I had to summarize 2013 with a single word, it would have to be ‘more’. We end this year with more analytical applications, more markets served, higher satisfaction among more users, and much more…

Reflections on Bayer’s 2014 Plan of Action Event

, , ,
Last week was a truly invigorating experience. Along with Doron Aspitz, Verix’s CEO and Yaron Makleff, Director of Services, I attended Bayer’s annual POA (Plan of Action) event at the Rosen Shingle Creek hotel in Orlando, FL. Bayer’s…

Four common mistakes when planning a new drug launch …..and how to avoid them

In the fiercely competitive Life Sciences market, the launch period of a new drug or medical device is most critical to its overall success. Alas, there is a lot of uncertainty and ambiguity during the first months of any new product in the…